These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25042283)

  • 1. Superior survival using living donors and donor-recipient matching using a novel living donor risk index.
    Goldberg DS; French B; Abt PL; Olthoff K; Shaked A
    Hepatology; 2014 Nov; 60(5):1717-26. PubMed ID: 25042283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
    Thuluvath PJ; Yoo HY
    Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
    Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable short- and long-term outcomes in deceased-donor and living-donor liver retransplantation.
    Chok KSH; Chan ACY; Fung JYY; Dai WC; Cheung TT; Lo CM
    Hepatol Int; 2017 Nov; 11(6):517-522. PubMed ID: 28936686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
    Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing practice and acceptable outcomes of high-MELD living donor liver transplantation in the USA.
    Anouti A; Patel MS; VanWagner LB; Lee WM; Asrani SK; Mufti AR; Rich NE; Vagefi PA; Shah JA; Kerr TA; Pedersen M; Hanish S; Singal AG; Cotter TG
    Liver Transpl; 2024 Jan; 30(1):72-82. PubMed ID: 37490432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is left lobe adult-to-adult living donor liver transplantation ready for widespread use? The US experience (1998-2010).
    Saidi RF; Jabbour N; Li Y; Shah SA; Bozorgzadeh A
    HPB (Oxford); 2012 Jul; 14(7):455-60. PubMed ID: 22672547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in partial liver transplantation: deceased donor split-liver vs. live donor liver transplantation.
    Saidi RF; Jabbour N; Li Y; Shah SA; Bozorgzadeh A
    HPB (Oxford); 2011 Nov; 13(11):797-801. PubMed ID: 21999593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of living donor liver transplantation on long-term cardiometabolic and graft outcomes in cirrhosis due to nonalcoholic steatohepatitis.
    Karnam RS; Azhie A; Yang C; Rogalsky A; Chen S; Xu W; Patel K; Selzner N; Lilly L; Cattral M; Bhat M
    Clin Transplant; 2023 Sep; 37(9):e15008. PubMed ID: 37143204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
    Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
    Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End-Stage Liver Disease Scores <30.
    Kitajima T; Moonka D; Yeddula S; Collins K; Rizzari M; Yoshida A; Abouljoud MS; Nagai S
    Liver Transpl; 2021 Jul; 27(7):971-983. PubMed ID: 33492764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of domino liver transplantation compared to deceased donor liver transplantation: a propensity-matching approach.
    Geyer ED; Burrier C; Tumin D; Hayes D; Black SM; Washburn WK; Tobias JD
    Transpl Int; 2018 Nov; 31(11):1200-1206. PubMed ID: 29907976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing 10-yr renal outcomes in deceased donor and living donor liver transplants.
    Sandal S; Almudevar A; Parajuli S; Bose A
    Clin Transplant; 2015 Dec; 29(12):1140-7. PubMed ID: 26383173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary non-resectable liver tumors: A single-center living-donor and deceased-donor liver transplantation case series.
    Lerut J; Iesari S; Vandeplas G; Fabbrizio T; Ackenine K; Núñez MEI; Komuta M; Coubeau L; Ciccarelli O; Bonaccorsi-Riani E
    Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):412-422. PubMed ID: 31521538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.
    Zimmerman MA; Baker T; Goodrich NP; Freise C; Hong JC; Kumer S; Abt P; Cotterell AH; Samstein B; Everhart JE; Merion RM
    Liver Transpl; 2013 Mar; 19(3):259-67. PubMed ID: 23495079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.
    Yim SH; Kim DG; Kang M; Koh HH; Choi MC; Min EK; Lee JG; Kim MS; Joo DJ
    Int J Surg; 2023 Nov; 109(11):3459-3466. PubMed ID: 37565633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after LDLT in recipients ≥70 years old in the United States. An OPTN/UNOS liver transplant registry analysis.
    Robinson T; Vargas PA; Oberholzer J; Pelletier S; Goldaracena N
    Clin Transplant; 2023 Nov; 37(11):e15099. PubMed ID: 37589889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.